Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ross D Hannan

Showing results (11-20 of 106) with videos related to

Pageof 11
Sort By:
Frontiers in Oncology|February 21, 2015
Implications of epithelial-mesenchymal plasticity for heterogeneity in colorectal cancerLloyd Pereira, John M Mariadason, Ross D Hannan, et al.
Growth Factors (Chur, Switzerland)|October 6, 2010
Second AKT: the rise of SGK in cancer signallingMaressa A Bruhn, Richard B Pearson, Ross D Hannan, et al.
Pulmonary Pharmacology & Therapeutics|June 28, 2005
Tackling the EGFR in pathological tissue remodellingHsiu-Wen Chan, Nicola J Smith, Ross D Hannan, et al.
Biochimica Et Biophysica Acta|December 3, 2014
The nucleolus as a fundamental regulator of the p53 response and a new target for cancer therapySimone J Woods, Katherine M Hannan, Richard B Pearson, et al.
Nature Reviews. Cancer|April 25, 2013
Dysregulation of the basal RNA polymerase transcription apparatus in cancerMegan J Bywater, Richard B Pearson, Grant A McArthur, et al.
Fly|January 20, 2011
Hfp, the Drosophila homolog of the mammalian c-myc transcriptional-repressor and tumor suppressor FIR, inhibits dmyc transcription and cell growthNicola J Cranna, Naomi C Mitchell, Ross D Hannan, et al.
Molecular Endocrinology (Baltimore, Md.)|June 19, 2004
Urotensin II promotes hypertrophy of cardiac myocytes via mitogen-activated protein kinasesDöne Onan, Luisa Pipolo, Eunice Yang, et al.
Cancer Management and Research|September 7, 2013
AKT-independent PI3-K signaling in cancer - emerging role for SGK3Maressa A Bruhn, Richard B Pearson, Ross D Hannan, et al.
IUBMB Life|March 2, 2011
Signaling to the ribosome in cancer--It is more than just mTORC1Katherine M Hannan, Elaine Sanij, Nadine Hein, et al.
Trends in Molecular Medicine|August 20, 2013
The nucleolus: an emerging target for cancer therapyNadine Hein, Katherine M Hannan, Amee J George, et al.
Pageof 11

Showing results (11-20 of 106) with videos related to

Sort By:
Pageof 11
Frontiers in Oncology|February 21, 2015
Implications of epithelial-mesenchymal plasticity for heterogeneity in colorectal cancerLloyd Pereira, John M Mariadason, Ross D Hannan, et al.
Growth Factors (Chur, Switzerland)|October 6, 2010
Second AKT: the rise of SGK in cancer signallingMaressa A Bruhn, Richard B Pearson, Ross D Hannan, et al.
Pulmonary Pharmacology & Therapeutics|June 28, 2005
Tackling the EGFR in pathological tissue remodellingHsiu-Wen Chan, Nicola J Smith, Ross D Hannan, et al.
Biochimica Et Biophysica Acta|December 3, 2014
The nucleolus as a fundamental regulator of the p53 response and a new target for cancer therapySimone J Woods, Katherine M Hannan, Richard B Pearson, et al.
Nature Reviews. Cancer|April 25, 2013
Dysregulation of the basal RNA polymerase transcription apparatus in cancerMegan J Bywater, Richard B Pearson, Grant A McArthur, et al.
Fly|January 20, 2011
Hfp, the Drosophila homolog of the mammalian c-myc transcriptional-repressor and tumor suppressor FIR, inhibits dmyc transcription and cell growthNicola J Cranna, Naomi C Mitchell, Ross D Hannan, et al.
Molecular Endocrinology (Baltimore, Md.)|June 19, 2004
Urotensin II promotes hypertrophy of cardiac myocytes via mitogen-activated protein kinasesDöne Onan, Luisa Pipolo, Eunice Yang, et al.
Cancer Management and Research|September 7, 2013
AKT-independent PI3-K signaling in cancer - emerging role for SGK3Maressa A Bruhn, Richard B Pearson, Ross D Hannan, et al.
IUBMB Life|March 2, 2011
Signaling to the ribosome in cancer--It is more than just mTORC1Katherine M Hannan, Elaine Sanij, Nadine Hein, et al.
Trends in Molecular Medicine|August 20, 2013
The nucleolus: an emerging target for cancer therapyNadine Hein, Katherine M Hannan, Amee J George, et al.
Pageof 11